[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646829":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":32,"locations":40,"responsibleParty":60,"collaborators":62,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":18,"enrollmentInfo":80,"targetDuration":18,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":43,"whyStopped":18,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Medical University Innsbruck","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Digital atrial fibrillation screening and management","EXPERIMENTAL","Participants assigned to the experimental arm are offered access to the 'Pulskontrolle' app. The app supports smartphone-camera photoplethysmography recordings for atrial fibrillation screening, digital education, and atrial fibrillation management support. Participants with suspected atrial fibrillation undergo confirmatory 7-day ECG patch monitoring. Confirmed atrial fibrillation triggers structured digital and telehealth-supported guidance according to guideline-oriented care pathways.",[13],"Device: Smartphone-based digital atrial fibrillation screening and management pathway",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care","NO_INTERVENTION","Participants assigned to the control arm receive usual care.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","Smartphone-based digital atrial fibrillation screening and management pathway","Participants randomized to the digital intervention arm receive access to a smartphone-based atrial fibrillation screening and management pathway. The intervention includes photoplethysmography-based pulse wave measurements using a CE-certified smartphone application, followed by confirmatory 7-day ECG patch monitoring in participants with abnormal findings suggestive of atrial fibrillation. Participants with suspected or confirmed atrial fibrillation receive structured digital information, adherence support, and the option of telehealth guidance to facilitate guideline-oriented care. Treatment decisions remain the responsibility of the participant's usual treating physician.",[9],[26,29],{"name":27,"affiliation":5,"role":28},"Axel Bauer","STUDY_CHAIR",{"name":30,"affiliation":5,"role":31},"Sebastian J Reinstadler, MD, PhD","PRINCIPAL_INVESTIGATOR",[33,37],{"name":30,"role":34,"phone":35,"phoneExt":18,"email":36},"CONTACT","+4351250425621","sebastian-johannes.reinstadler@i-med.ac.at",{"name":38,"role":34,"phone":18,"phoneExt":18,"email":39},"Michael Schreinlechner, MD","Michael.Schreinlechner@i-med.ac.at",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Department of Internal Medicine III, Medical University Innsbruck","RECRUITING","Innsbruck","Tyrol","6020","Austria","AT",{"type":50,"coordinates":51},"Point",[52,53],11.39454,47.26266,{"lat":53,"lon":52},[56,58],{"name":38,"role":34,"phone":35,"phoneExt":18,"email":57},"michael.schreinlechner@i-med.ac.at",{"name":30,"role":34,"phone":18,"phoneExt":18,"email":59},"Sebastian-Johannes.Reinstadler@i-med.ac.at",{"type":61,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[63,65,67],{"name":64,"class":6},"AIT Austrian Institute of Technology GmbH",{"name":66,"class":6},"Medical University of Graz",{"name":68,"class":69},"UMIT Tirol","UNKNOWN","100646829","digital-screening-for-atrial-fibrillation-to-prevent-stroke-100646829",false,"NCT07684053","Digital Screening for Atrial Fibrillation to Prevent Stroke","Digital Screening for Atrial Fibrillation to Prevent Stroke: The Randomized Austrian Digital Heart Study","ADHP","Inclusion Criteria\n\n1. Age ≥ 65 years\n2. Policyholder in Austria (active unique social insurance number)\n3. Written electronic informed consent Exclusion Criteria\n\na) Currently treated with oral anticoagulation b) Cardiac implanted electronic device (CIED)","ALL","65 Years",{"count":81,"type":82},100060,"ESTIMATED","INTERVENTIONAL",[85],"NA","The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.",[88,89],"Atrial Fibrillation (Prevention of Stroke)","Stroke",[91,92,93,94,95,96,97,98,99],"Digital Health","Atrial Fibrillation Screening","Photoplethysmography","Smartphone","ECG Patch","Stroke Prevention","Randomized Controlled Trial","Siteless Trial","Telehealth","2026-06-29",{"date":102,"type":103},"2026-07-06","ACTUAL",{"date":100,"type":82},{"date":106,"type":82},"2032-06-01",{"name":5,"class":6},1]